Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07266571 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 1, 2027 → Nov 1, 2027
See other at-risk trials from University of Alabama at Birmingham

Record History

  1. Start date: Aug 1, 2026 to Nov 1, 2026 Primary and study completion pushed from Aug 1, 2027 to Nov 1, 2027 · Eligibility criteria expanded, about 18 words · Site contact updated Show 3 more changesShow less
    • Primary and study completion pushed from Aug 1, 2027 to Nov 1, 2027
    • Eligibility criteria expanded, about 18 words
    • Site contact updated
  2. Start date: May 1, 2026 to Aug 1, 2026 Primary and study completion pushed from May 1, 2027 to Aug 1, 2027v3 Show 1 more changeShow less
    • Primary and study completion pushed from May 1, 2027 to Aug 1, 2027
  3. Start date: Feb 1, 2026 to May 1, 2026 Primary endpoints revised (2) · Primary and study completion dates: Feb 1, 2027 to May 1, 2027 · Eligibility criteria revised · 1 morev2 Show 4 more changesShow less
    • Primary endpoints revised (2)
    • Primary and study completion dates: Feb 1, 2027 to May 1, 2027
    • Eligibility criteria revised
    • Study description expanded, about 12 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to determine how pycnogenol may reduce Gulf War Illness (GWI) symptom severity. The study will also examine the safety of this treatment and determine the optimal dosage. The investigators believe that GWI involves inflammation in the body and brain that causes fatigue, pain, cognitive disruption, and other symptoms. Botanicals that reduce inflammation may help treat GWI.
Trial Details
NCT Number NCT07266571
Lead Sponsor University of Alabama at Birmingham
Conditions Gulf War Syndrome
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov